全文获取类型
收费全文 | 23149篇 |
免费 | 2354篇 |
国内免费 | 1163篇 |
专业分类
耳鼻咽喉 | 168篇 |
儿科学 | 287篇 |
妇产科学 | 315篇 |
基础医学 | 4424篇 |
口腔科学 | 479篇 |
临床医学 | 1789篇 |
内科学 | 4523篇 |
皮肤病学 | 566篇 |
神经病学 | 1227篇 |
特种医学 | 442篇 |
外国民族医学 | 12篇 |
外科学 | 3004篇 |
综合类 | 3077篇 |
现状与发展 | 5篇 |
预防医学 | 888篇 |
眼科学 | 342篇 |
药学 | 2124篇 |
3篇 | |
中国医学 | 341篇 |
肿瘤学 | 2650篇 |
出版年
2024年 | 29篇 |
2023年 | 489篇 |
2022年 | 671篇 |
2021年 | 1716篇 |
2020年 | 1175篇 |
2019年 | 1437篇 |
2018年 | 1272篇 |
2017年 | 1010篇 |
2016年 | 819篇 |
2015年 | 961篇 |
2014年 | 1402篇 |
2013年 | 1279篇 |
2012年 | 1288篇 |
2011年 | 1458篇 |
2010年 | 1246篇 |
2009年 | 1301篇 |
2008年 | 1227篇 |
2007年 | 1131篇 |
2006年 | 1010篇 |
2005年 | 821篇 |
2004年 | 679篇 |
2003年 | 546篇 |
2002年 | 345篇 |
2001年 | 371篇 |
2000年 | 282篇 |
1999年 | 246篇 |
1998年 | 254篇 |
1997年 | 217篇 |
1996年 | 145篇 |
1995年 | 168篇 |
1994年 | 146篇 |
1993年 | 118篇 |
1992年 | 110篇 |
1991年 | 94篇 |
1990年 | 70篇 |
1989年 | 77篇 |
1988年 | 72篇 |
1987年 | 61篇 |
1986年 | 60篇 |
1985年 | 106篇 |
1984年 | 108篇 |
1983年 | 77篇 |
1982年 | 85篇 |
1981年 | 90篇 |
1980年 | 85篇 |
1979年 | 59篇 |
1978年 | 69篇 |
1977年 | 32篇 |
1976年 | 47篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
31.
目的探讨膝关节骨软骨损伤评估、治疗方法以及疗效。方法2010 年 1 月—2016 年 1 月,收治 17 例膝关节骨软骨损伤患者。男 2 例,女 15 例;年龄 15~33 岁,平均 19.3 岁。致伤原因:扭伤 14 例,膝关节过伸、内翻暴力致伤 3 例。骨软骨骨折部位:髌骨 8 例,股骨外髁 4 例,股骨内髁 1 例,胫骨平台 4 例。新鲜骨折 15 例,陈旧性骨折 2 例。术前膝关节 Lysholm 评分为(31.6±2.3)分。14 例骨软骨骨折切开复位后,根据骨质情况分别选择可吸收棒(9 例)、可吸收软骨钉(3 例)或可吸收缝线(2 例)固定;3 例骨块位于胫骨内侧平台边缘非负重区直接取出。结果术后 1 例发生切口脂肪液化,再次清创后愈合;其余患者切口均Ⅰ期愈合。患者均获随访,随访时间 6 个月~2 年,平均 13 个月。14 例行内固定患者中,13 例骨折愈合良好,1 例髌骨骨软骨骨折未愈合;3 例非负重区骨软骨取出患者,随访期间未见膝关节内侧关节间隙变窄及创伤性关节炎发生。术后 1 年,膝关节 Lysholm 评分为(91.3±1.1)分,较术前明显改善(t=7.136,P=0.001)。 结论对于膝关节骨软骨损伤,骨软骨骨块带有全层松质骨时可选择切开复位内固定,带点状松质骨时可直接取出。 相似文献
32.
33.
Natasa Strbo Irena Pastar Laura Romero Vivien Chen Milos Vujanac Andrew P. Sawaya Ivan Jozic Andrea D. F. Ferreira Lulu L. Wong Cheyanne Head Olivera Stojadinovic Denisse Garcia Katelyn O'Neill Stefan Drakulich Seth Taller Robert S. Kirsner Marjana Tomic‐Canic 《Experimental dermatology》2019,28(3):225-232
34.
35.
36.
《Journal of pharmaceutical sciences》2019,108(8):2661-2667
In order to evaluate the in vivo effect of inhaled formulations, it is a gold standard to create a lung metastasis model by intravenously injecting cancer cells into an animal. Because the cancer grows from the blood vessel side, there is a possibility of underestimating the effect of an inhaled formulation administered to the lung epithelium side. In addition, the metastasis model has disadvantages in terms of preparation time and expense. The present study aimed to establish a new method to evaluate the effect of an inhaled small interfering RNA (siRNA) formulation that is more correct, more rapid, and less expensive. We investigated whether siRNA can suppress gene expression of plasmid DNA (pDNA) by serial pulmonary administration of siRNA and pDNA powders prepared by spray-freeze-drying. We revealed that formulations of dry siRNA powder significantly suppressed gene expression of pDNA powder compared with a control group with no siRNA. Naked siRNA inhalation powder with no vector showed the suppression of gene expression equivalent to that of an siRNA-polyethyleneimine complex without damaging tissues. These results show that the present method is suitable for evaluating the gene-silencing effect of inhaled siRNA powders. 相似文献
37.
miR-30c has been acknowledged as a tumor suppressor in various human cancers, such as ovarian cancer, gastric cancer, and prostate cancer. However, the role of miR-30c in glioblastoma (GBM) needs to be investigated.
In our study, we found that the expression of miR-30c was significantly downregulated in GBM tissues and
cell lines. We found that overexpression of miR-30c inhibited cellular proliferation of GBM cells in vitro and
in vivo. More GBM cells were arrested in the G0 phase after miR-30c overexpression. Moreover, we showed
that miR-30c overexpression suppressed the migration and invasion of GBM cells. Mechanistically, we found
that SOX9 was a direct target of miR-30c in GBM cells. Overexpression of miR-30c inhibited the mRNA
and protein levels of SOX9 in GBM cells. Moreover, there was a negative correlation between the expression
of miR-30c and SOX9 in GBM tissues. Finally, we showed that restoration of SOX9 in GBM cells reversed
the proliferation, migration, and invasion of GBM cells transfected with miR-30c mimic. Collectively, our
results demonstrated that miR-30c suppressed the proliferation, migration, and invasion of GBM cells via
targeting SOX9. 相似文献
38.
Hui Fan Xianzhen Jin Chunyan Liao Lina Qiao Wei Zhao 《Pathology, research and practice》2019,215(11):152667
MicroRNAs (miRNAs) have been found to be aberrantly expressed and exert essential roles in the tumorigenesis and progression of gastric cancer (GC). miR-301b-3p has been recognized as a cancer-related miRNA in lung cancer, bladder cancer and hepatocellular carcinoma. However, the function of miR-301b-3p in GC progression and its underlying mechanism have not been studied yet. In this study, we found that miR-301b-3p expression was up-regulated in GC tissues compared to adjacent noncancerous tissues. Furthermore, the elevated levels of miR-301b-3p were detected in GC cell lines (SGC-7901, AGS, MKN-45 and MGC-803) as compared with GES-1 cells. Interestingly, GC tissues from patients with tumor size ≥ 5 cm and advanced tumor stages showed obvious higher levels of miR-301b-3p compared to matched controls. Functionally, miR-301b-3p knockdown prominently inhibited cell proliferation, and induced cell cycle arrest at G1 phase and apoptosis in MGC-803 cells. Meanwhile, ectopic expression of miR-301b-3p conversely regulated these biological behaviors of MKN-45 cells. Next, we found that miR-301b-3p knockdown increased, whereas miR-301b-3p overexpression reduced the expression of zinc finger and BTB domain containing 4 (ZBTB4) in GC cells. Accordingly, luciferase reporter assay identified ZBTB4 as a direct target of miR-301b-3p. ZBTB4 overexpression markedly restrained the growth of MGC-803 cells. More importantly, ZBTB4 silencing partially reversed miR-301b-3p knockdown-induced tumor suppressive effects on MGC-803 cells. In conclusion, we firstly revealed that miR-301-3p was highly expressed in GC and contributed to tumor progression via attenuating ZBTB4, which might provide a novel molecular-targeted strategy for GC treatment. 相似文献
39.
Xinran Wang Ying Jia Huiyan Deng Yao Liu Yueping Liu 《Pathology, research and practice》2019,215(2):308-314
Recent studies have shown that intratumoral heterogeneity is prevalent in esophageal squamous cell cancer (ESCC) based on DNA sequencing and chromosome analysis in multiple regions from the same tumor. This study aimed to investigate the expression of ZNF750, EP300, MTOR and KMT2D and their intratumoral heterogeneity (ITH) in patients with ESCC. A total of 106 cases, who underwent esophagectomy from 2008 to 2010, with two foci from each case, were tested by immunohistochemistry(IHC) as well as 12 cases were tested by RNAscope in this study.We found that 58/106 (54.72%), 66/106 (62.26%), 75/106 (70.75%%) of ESCC showed high expression of ZNF750, EP300, MTOR, respectively by IHC, and 8/12 (66.67%), 10/12 (83.33%), 4/12 (33.33%) and 6/12 (50%) showed high expression of ZNF750, EP300, MTOR and KMT2D, respectively by RNAscope. Multivariate analysis showed that MTOR expression was an independent infavorable prognostic factor of overall survival (OS) (HR?=?1.921; P?=?0.000). This study also found that 44/106(4151%), 37/106 (34.91%), 39/106(36.79%) of ESCC showed heterogeneous expression of ZNF750, EP300 and MTOR respectively by IHC, 8/12(66.67%), 8/12(66.67%), 4/12(33.33%), 4/12(33.33%) of ZNF750, EP300, MTOR and KMT2D respectively by RNAscope, IHC and RNAscope could successfully detect a high prevalence of ITH. In conclusion, findings of this study showed that ZNF750, EP300, MTOR and KMT2D heterogeneously expressed in ESCC. High expression of ZNF750 related to a better outcome, while EP300 and MTOR related to a poor prognosis. 相似文献
40.